Ivan Raimondi

Cornell University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index2.1kcitations73works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Research and Splicing(24), RNA modifications and cancer(19), Neuroblastoma Research and Treatments(15), Cancer, Hypoxia, and Metabolism(14), Cancer Cells and Metastasis(13)

Publications73 total

A comprehensive view of somatic mosaicism by single-cell DNA analysis
2025· 3 citedOpen Access
Large-scale single-cell phylogenetic mapping of clonal evolution in the human aging esophagus
2025· 2 citedOpen Access
Single-cell mapping of regulatory DNA:Protein interactions
2025Open Access
Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling
Nature Biotechnology·2024· 12 cited
GoT-ChA: Genotyping of Targeted loci with single-cell Chromatin Accessibility v1
2024Open Access
YTHDC1 m6A-dependent and m6A-independent functions converge to preserve the DNA damage response
The EMBO Journal·2024· 11 citedOpen Access
Single-cell genotype-phenotype mapping identifies therapeutic vulnerabilities in VEXAS syndrome
2024· 11 citedOpen Access
YTHDC1 m6A-dependent and m6A-independent functions converge to preserve DNA damage response.
2024· 2 citedOpen Access
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1
EMBO Molecular Medicine·2024· 20 citedOpen Access
supplemental figure legend from The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial–Mesenchymal Transition in Breast Cancer
2023Open Access
supplemental material from The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial–Mesenchymal Transition in Breast Cancer
2023Open Access
supplemental figure 4 from The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial–Mesenchymal Transition in Breast Cancer
2023Open Access
supplemental figure 4 from The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial–Mesenchymal Transition in Breast Cancer
2023Open Access
Table S1 from Subcellular Distribution of p53 by the p53-Responsive lncRNA <i>NBAT1</i> Determines Chemotherapeutic Response in Neuroblastoma
2023Open Access
Table S4 from Subcellular Distribution of p53 by the p53-Responsive lncRNA <i>NBAT1</i> Determines Chemotherapeutic Response in Neuroblastoma
2023Open Access
Table S3 from Subcellular Distribution of p53 by the p53-Responsive lncRNA <i>NBAT1</i> Determines Chemotherapeutic Response in Neuroblastoma
2023Open Access
Data from The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial–Mesenchymal Transition in Breast Cancer
2023Open Access
Supplementary Data from Subcellular Distribution of p53 by the p53-Responsive lncRNA <i>NBAT1</i> Determines Chemotherapeutic Response in Neuroblastoma
2023Open Access
Table S2 from Subcellular Distribution of p53 by the p53-Responsive lncRNA <i>NBAT1</i> Determines Chemotherapeutic Response in Neuroblastoma
2023Open Access
Data from The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial–Mesenchymal Transition in Breast Cancer
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Maite Huarte(17), Alberto Inga(16), Elisa Latorre(9), Stephana Carelli(9), Vito D’Agostino(9), Ilaria Castiglioni(9), Chiara Zucal(9), Giacomina Moro(9), Andrea Luciani(9), G Ghilardi(9), Eleonora Monti(9), Anna Maria Di Giulio(9), Alfredo Gorio(9), Alessandro Provenzani(9), Prasanna Kumar Juvvuna(8), Chandrasekhar Kanduri(8), Sanhita Mitra(7), Somsundar Veppil Muralidharan(7), Mirco Di Marco(7), Subazini Thankaswamy Kosalai(7)